New therapeutic strategy with SMTP for acute cerebral ischemia
Project/Area Number |
23791582
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Cerebral neurosurgery
|
Research Institution | Tohoku University |
Principal Investigator |
SAITO Atsushi 東北大学, 医学系研究科, 非常勤講師 (60375053)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 実験脳外科学 / 脳梗塞 / 国際情報交流 |
Research Abstract |
We evaluated effectiveness of SMTP for acute cerebral ischemia using mouse transient focal cerebral ischemia model. SMTP was intravenously injected and successfully reduced size of cerebral infarction compared with the vehicle group. Cerebral blood flow analysis demonstrated that SMTP reduced remarkable increase of CBF after reperfusion and induced gradual CBF recovery. Superoxide production, radical reactive production and endothelial destruction marker was significantly reduced in SMTP-treated group compared with the vehicle group. Our results indicate that SMTP administration might induce not only fibrinolytic effectiveness, but also anti-oxidative injury after reperfusion due to transient cerebral ischemia.
|
Report
(3 results)
Research Products
(2 results)
-
-
[Journal Article] Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain.2011
Author(s)
Akamatsu Y, Saito A, Fujimura M, Shimizu H, Mekawy M, Hasumi K, Tominaga T
-
Journal Title
Neuroscience Letter
Volume: 503
Pages: 110-114
Related Report
Peer Reviewed